BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of $14.99 billion. The enterprise value is $12.74 billion.
| Market Cap | 14.99B |
| Enterprise Value | 12.74B |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BeiGene has 104.04 million shares outstanding.
| Shares Outstanding | 104.04M |
| Owned by Insiders (%) | 19.83% |
| Owned by Institutions (%) | 48.10% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.10 |
| Forward PS | 0.71 |
| PB Ratio | 4.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.32 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 12.16 |
Financial Efficiency
Return on equity (ROE) is -23.10% and return on invested capital (ROIC) is -27.03%.
| Return on Equity (ROE) | -23.10% |
| Return on Assets (ROA) | -15.30% |
| Return on Capital (ROIC) | -27.03% |
| Revenue Per Employee | $231,960 |
| Profits Per Employee | -$83,180 |
| Employee Count | 10,600 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.09 |
Taxes
In the past 12 months, BeiGene has paid $55.87 million in taxes.
| Income Tax | 55.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.01% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been lower than the market average.
| Beta (1Y) | 0.63 |
| 52-Week Price Change | -44.01% |
| 50-Day Moving Average | 154.34 |
| 200-Day Moving Average | 176.63 |
| Relative Strength Index (RSI) | 47.65 |
| Average Volume (30 Days) | 244,953 |
Short Selling Information
| Short Interest | 1.73M |
| Short Previous Month | 1.73M |
| Short % of Shares Out | 5.88% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.43 |
Income Statement
In the last 12 months, BeiGene had revenue of $2.46 billion and -$881.71 million in losses. Loss per share was -$0.65.
| Revenue | 2.46B |
| Gross Profit | 2.08B |
| Operating Income | -1.21B |
| Pretax Income | -825.84M |
| Net Income | -881.71M |
| EBITDA | -812.17M |
| EBIT | -899.85M |
| Loss Per Share | -$0.65 |
Balance Sheet
The company has $3.19 billion in cash and $930.19 million in debt, giving a net cash position of $2.26 billion or $21.68 per share.
| Cash & Cash Equivalents | 3.19B |
| Total Debt | 930.19M |
| Net Cash | 2.26B |
| Net Cash Per Share | $21.68 |
| Equity / Book Value | 3.54B |
| Book Value Per Share | 34.00 |
| Working Capital | 2.39B |
Cash Flow
In the last 12 months, operating cash flow was -$1.16 billion and capital expenditures -$561.90 million, giving a free cash flow of -$1.72 billion.
| Operating Cash Flow | -1.16B |
| Capital Expenditures | -561.90M |
| Free Cash Flow | -1.72B |
| FCF Per Share | -$16.48 |
Margins
Gross margin is 84.55%, with operating and profit margins of -49.12% and -35.86%.
| Gross Margin | 84.55% |
| Operating Margin | -49.12% |
| Pretax Margin | -33.59% |
| Profit Margin | -35.86% |
| EBITDA Margin | -33.03% |
| EBIT Margin | -36.60% |
| FCF Margin | -69.93% |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.22% |
| Shareholder Yield | -1.22% |
| Earnings Yield | -5.88% |
| FCF Yield | -11.47% |
Analyst Forecast
The average price target for BeiGene is $254.23, which is 76.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $254.23 |
| Price Target Difference | 76.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 83.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 2.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.45 |
| Piotroski F-Score | 3 |